(R)-4-Methyloxazolidin-2-one → HCID 71252233, compound

HRID 2411961Notes

Reaction equation

HRID 2411961 reaction equation
Cl[C:2]1[N:7]=[N:6][C:5]([C:8]([N:10]2[CH2:15][CH2:14][N:13]([C:16]3[C:21]([CH3:22])=[CH:20][C:19]([CH3:23])=[CH:18][N:17]=3)[CH2:12][CH2:11]2)=[O:9])=[CH:4][CH:3]=1.[CH3:24][C@@H:25]1[CH2:29][O:28][C:27](=[O:30])[NH:26]1>>[CH3:22][C:21]1[C:16]([N:13]2[CH2:14][CH2:15][N:10]([C:8]([C:5]3[N:6]=[N:7][C:2]([N:26]4[C@H:25]([CH3:24])[CH2:29][O:28][C:27]4=[O:30])=[CH:3][CH:4]=3)=[O:9])[CH2:11][CH2:12]2)=[N:17][CH:18]=[C:19]([CH3:23])[CH:20]=1

Participants

3

Reactant 2

HCID 2734858(R)-4-Methyloxazolidin-2-oneHCID 86676766HCID 86676766, compound

Product 1

HCID 71252233HCID 71252233, compoundYield 50.8%

Procedure

Using (6-chloropyridazin-3-yl)[4-(3,5-dimethylpyridin-2-yl)piperazin-1-yl]methanone (28 mg) described in Preparation Example 230 and (R)-4-methyloxazolidin-2-one (10 mg) and by the reaction and treatment in the same manner as in Example 1, the title compound (17 mg) was obtained.

Sources & evidence

ORD record
ord-0a8a5459bade4f96be5933aafe5c774a
Source dataset
uspto-grants-2014_08
Patent number
US08816079B2

Reaction notes

Loading…